16. Gene Silencing: A New Era in Heart Disease Prevention

Lepodisiran is at the forefront of a new era in heart disease prevention, using gene-silencing technology to tackle hereditary cardiovascular risks at their source.
Other therapies employing similar RNA interference strategies are also in the pipeline, which could soon provide a range of options for patients with genetic heart risk factors.
For background on these groundbreaking approaches, see
Nature Reviews Cardiology.